首页> 外文期刊>Current Problems in Cancer >Using the Surveillance, Epidemiology, and End Results Database to Investigate Rare Cancers, Second Malignancies, and Trends in Epidemiology, Treatment, and Outcome Rare Cancers
【24h】

Using the Surveillance, Epidemiology, and End Results Database to Investigate Rare Cancers, Second Malignancies, and Trends in Epidemiology, Treatment, and Outcome Rare Cancers

机译:使用监视,流行病学和最终结果数据库调查罕见癌,第二恶性肿瘤以及流行病学,治疗和结局罕见癌的趋势

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The study of rare cancers has been a particularly active area of investigation with Surveillance, Epidemiology, and End Results (SEER) Program data. Although the definition of a rare cancer can be described broadly as a cancer with a low incidence or prevalence, the study of rare cancers is not limited to obscure histologic types that are diagnosed infrequently. It can also include cancers that constitute a rare or difficult-to-study subtype of a more common cancer, such as T4N0 breast cancer. Alternately, rare cancers can be rare occurrences of relatively common histologic types occurring in uncommon locations, such as adenoid cystic carcinoma of the breast. Finally, rare occurrences of common cancers occurring in uncommon hosts, such as male breast cancer, also lend themselves to population-based study using SEER.
机译:监视,流行病学和最终结果(SEER)计划数据对稀有癌症的研究一直是特别活跃的研究领域。尽管稀有癌症的定义可以广义地描述为发生率低或患病率低的癌症,但是对稀有癌症的研究并不局限于很少被诊断的组织学类型模糊。它还可以包括构成更常见癌症的罕见或难以研究的亚型的癌症,例如T4N0乳腺癌。或者,稀有癌症可以是在罕见位置发生的相对常见的组织学类型的稀有发生,例如乳腺癌的腺样囊性癌。最后,在罕见的宿主中发生的常见癌症的罕见发生,例如男性乳腺癌,也有助于使用SEER进行基于人群的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号